
Glimleno PM 1mg/15mg/500mg Tablet
Marketer
Zamixo Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimleno PM 1mg/15mg/500mg Tablet
Combiflex DM tablets (1mg/15mg/500mg) combine medications to manage blood glucose in adults with type 2 diabetes. This treatment complements diet and exercise to enhance blood sugar regulation, promoting efficient insulin use and reducing elevated glucose levels. Always adhere to your physician's prescribed dosage and regimen. Take with food to minimize digestive discomfort. If a dose is missed, take it immediately unless your next dose is imminent; then, skip the missed dose and resume your usual schedule. Never double the dose. Overdosage risks dangerously low blood sugar (hypoglycemia). Concurrently using other diabetes medications, alcohol, or skipping meals increases hypoglycemia risk; regular blood glucose monitoring is vital. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose any kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Kidney function tests are typically performed before treatment initiation. Limit alcohol consumption to lessen potential side effects.
Primary Ingredients of Glimleno PM 1mg/15mg/500mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glimleno PM 1mg/15mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Glimleno PM 1mg/15mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glimleno PM 1mg/15mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. This medication should be administered with a meal.
Common Side effects of Glimleno PM 1mg/15mg/500mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimleno PM 1mg/15mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Glimleno PM 1mg/15mg/500mg Tablet with a meal.
How Glimleno PM 1mg/15mg/500mg Tablet works:
Glimleno PM, a 1mg/15mg/500mg tablet, combines the antidiabetic agents glimepiride, metformin, and pioglitazone. This triple therapy offers enhanced blood sugar management when monotherapy or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimleno PM 1mg/15mg/500mg tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimleno PM 1mg/15mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Glimleno PM 1mg/15mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimleno PM 1mg/15mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Glimleno PM 1mg/15mg/500mg tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimleno PM 1mg/15mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glimleno PM 1mg/15mg/500mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimleno PM 1mg/15mg/500mg Tablet :
Should you forget to take your Glimleno PM 1mg/15mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimleno PM 1mg/15mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
